grid-line

Lykos therapeutics

2.4K
Volume
+4400%
Growth
regular

Turn Trends into Views🚀

Type in a topic to instantly see search volume, difficulty and related topics. All for free.

Free insights powered by
About the Topic

​Lykos Therapeutics, formerly known as MAPS Public Benefit Corporation (MAPS PBC), is a public benefit corporation focused on developing MDMA-assisted therapy for post-traumatic stress disorder (PTSD). Established in 2014 as a subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS), the company rebranded to Lykos Therapeutics in January 2024 to reflect its evolving mission. Lykos Therapeutics primarily serves individuals suffering from PTSD, aiming to provide innovative, evidence-based therapeutic options to improve mental health outcomes

Lykos therapeutics was discovered on July 31st 2024 and it currently has a search volume of 2.4K with a growth of +4400%.

Key Indicators
Growth
  • Exploding
  • Regular
  • Peaked
Speed
  • Exponential
  • Constant
  • Stationary
Seasonality
  • High
  • Medium
  • Low
Volatility
  • High
  • Average
  • Low
Members Only
Try Exploding Topics Pro
Get Free, Unlimited Access for 7 Days.
Related Topics

Save this topic and build your own trend dashboard.

Available with Exploding Topics Pro, try it now.